Hospital, Hong Kong. Further risk stratification may be appropriate to improve the cost-effectiveness of ICD therapy. In a prospective observational study, 1,018 Chinese patients who had LVEF #35%, New York Heart Association functional class II or III status, and >40 days after myocardial infarction did not undergo ICD implantation for various reasons (16) . During a mean follow-up of 2.8 years, all-cause mortality was 7.4%
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and SCD was 5%. Independent predictors of SCD included older age, LVEF #25%, and absence of coronary revascularization.
SCD IN HCM
The prevalence of HCM in China was 0.16%, which was comparable to the Western data, according to a population-based echocardiographic study on 8,080
Chinese adults (17) . In another long-term follow-up study in Chinese patients from Hong Kong, a high incidence of AF (35%) and nonobstructive apical hypertrophy (41%) were observed (18) . However, a low annual mortality rate of 1.6% was observed, compared with 5.6% in non-Asians (19 
